Anzeige
Meldung des Tages: MARKTALARM: EchoIQ rettet Leben – Anerkennung kommt JETZT

Immunic Aktie News

Aktie
WKN:  A2PHD4 ISIN:  US4525EP1011 US-Symbol:  IMUX Branche:  Biotechnologie Land:  USA
0,566 €
-0,017 €
-2,92%
12:34:28 Uhr
Depot/Watchlist
Marktkapitalisierung *
47,04 Mio. €
Streubesitz
61,15%
KGV
-0,79
Index-Zuordnung
-

Immunic News

05.06.25 - EQS
EQS-News: Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS
Issuer: Immunic AG / Key word(s): Study/Study results Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional ...
05.06.25 - PR Newswire
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER ...
03.06.25 - PR Newswire
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering PR Newswire
02.06.25 - EQS
EQS-News: Immunic to Participate in Investor, Scientific and Industry Conferences in June
Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Investor, Scientific and Industry Conferences in June 02.06.2025 / 12:30 CET/CEST The issuer is solely ...
02.06.25 - PR Newswire
Immunic to Participate in Investor, Scientific and Industry Conferences in June
Immunic to Participate in Investor, Scientific and Industry Conferences in June PR Newswire
29.05.25 - PR Newswire
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering PR Newswire
28.05.25 - PR Newswire
Immunic, Inc. Announces Proposed Public Offering
Immunic, Inc. Announces Proposed Public Offering PR Newswire
02.05.25 - EQS
EQS-News: Immunic to Participate in Scientific and Industry Conferences in May
Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Scientific and Industry Conferences in May 02.05.2025 / 12:30 CET/CEST The issuer is solely responsible ...
02.05.25 - PR Newswire
Immunic to Participate in Scientific and Industry Conferences in May
Immunic to Participate in Scientific and Industry Conferences in May PR Newswire
30.04.25 - EQS
EQS-News: Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial
Issuer: Immunic AG / Key word(s): Study results Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis ...
30.04.25 - PR Newswire
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial PR ...
10.04.25 - EQS
EQS-News: Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Issuer: Immunic AG / Key word(s): Financing Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments 10.04.2025 / 19:00 ...
10.04.25 - PR Newswire
Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments PR Newswire
09.04.25 - EQS
EQS-News: Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Issuer: Immunic AG / Key word(s): Financing Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments 09.04.2025 / 14:10 CET/CEST ...
09.04.25 - PR Newswire
Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments PR Newswire
01.04.25 - EQS
EQS-News: Immunic, Inc. to Participate in Scientific and Industry Conferences in April
Issuer: Immunic AG / Key word(s): Conference Immunic, Inc. to Participate in Scientific and Industry Conferences in April 01.04.2025 / 12:30 CET/CEST The issuer is solely ...
01.04.25 - PR Newswire
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
Immunic, Inc. to Participate in Scientific and Industry Conferences in April PR Newswire
03.03.25 - EQS
EQS-News: Immunic to Participate in Scientific and Investor Conferences in March
Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in March 03.03.2025 / 12:30 CET/CEST The issuer is solely responsible ...
03.03.25 - PR Newswire
Immunic to Participate in Scientific and Investor Conferences in March
Immunic to Participate in Scientific and Investor Conferences in March PR Newswire
26.02.25 - EQS
EQS-News: Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis
Issuer: Immunic AG / Key word(s): Conference/Study Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis ...

Newssuche

Videos

newspaper
22.01.26 -5,56%
Trading Insights vom 22.01.26
Preisschock bei Erdgas! Was sind die Gründe, wie geht man damit um? Gold auf neuem Allzeithoch: wie ... Mehr »